Fiscal Impact of Expanded Medicare Coverage for GLP-1 Receptor Agonists to Treat Obesity

Jennifer H. Hwang, Neda Laiteerapong, Elbert S. Huang, Dariush Mozaffarian, A. Mark Fendrick, David D. Kim

Open source

DOI
10.1001/jamahealthforum.2025.0905
Published
2025-04-25
Container
JAMA Health Forum
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamahealthforum.2025.0905,
  title = {Fiscal Impact of Expanded Medicare Coverage for GLP-1 Receptor Agonists to Treat Obesity},
  author = {Jennifer H. Hwang and Neda Laiteerapong and Elbert S. Huang and Dariush Mozaffarian and A. Mark Fendrick and David D. Kim},
  year = {2025},
  journal = {JAMA Health Forum},
  doi = {10.1001/jamahealthforum.2025.0905},
  url = {https://doi.org/10.1001/jamahealthforum.2025.0905}
}

RIS

TY  - JOUR
TI  - Fiscal Impact of Expanded Medicare Coverage for GLP-1 Receptor Agonists to Treat Obesity
AU  - Jennifer H. Hwang
AU  - Neda Laiteerapong
AU  - Elbert S. Huang
AU  - Dariush Mozaffarian
AU  - A. Mark Fendrick
AU  - David D. Kim
PY  - 2025
JO  - JAMA Health Forum
DO  - 10.1001/jamahealthforum.2025.0905
UR  - https://doi.org/10.1001/jamahealthforum.2025.0905
ER  - 

APA

Hwang, J. H., Laiteerapong, N., Huang, E. S., Mozaffarian, D., Fendrick, A. M., & Kim, D. D. (2025). Fiscal Impact of Expanded Medicare Coverage for GLP-1 Receptor Agonists to Treat Obesity. JAMA Health Forum. https://doi.org/10.1001/jamahealthforum.2025.0905

Source records